BACKGROUND AND PURPOSE: Crossed cerebellar diaschisis (CCD), the decrease in blood flow and metabolism in the cerebellar hemisphere contralateral to a supratentorial stroke, is frequently reported on positron-emission tomography (PET) and single-photon emission CT (SPECT) but is rarely described with MR perfusion techniques. This study was undertaken to determine the frequency of CCD observed in acute stroke by retrospective review of a research data base of patients with acute stroke evaluated by diffusion-weighted (DWI) and dynamic contrast susceptibility perfusion MR imaging (PWI). MATERIALS AND METHODS: PWI scans of 301 consecutive patients with acute stroke and positive DWI abnormality from a research data base were reviewed. Contralateral cerebellar hypoperfusion was identified by inspection of time-to-peak (TTP) maps for asymmetry with an absence of cerebellar abnormalities on T2-weighted scans, DWI, or disease of the vertebrobasilar system on MR angiography. In a subset of the cases, quantitative analysis of perfusion scans was performed using an arterial input function and singular value decomposition (SVD) to generate cerebral blood flow (CBF) maps. RESULTS: A total of 47 of 301 cases (15.61%) met the criteria of CCD by asymmetry of cerebellar perfusion on TTP maps. On quantitative analysis, there was corresponding reduction of CBF by 22.75 +/- 10.94% (range, 7.45% to 52.13%) of the unaffected cerebellar hemisphere). CONCLUSIONS: MR perfusion techniques can be used to detect CCD, though the frequency presented in this series is lower than that commonly reported in the PET/SPECT literature. Nevertheless, with its role in acute stroke and noninvasive nature, MR perfusion may be a viable alternative to PET or SPECT to study the phenomenon and clinical consequences of supratentorial stroke with CCD.
BACKGROUND AND PURPOSE: Crossed cerebellar diaschisis (CCD), the decrease in blood flow and metabolism in the cerebellar hemisphere contralateral to a supratentorial stroke, is frequently reported on positron-emission tomography (PET) and single-photon emission CT (SPECT) but is rarely described with MR perfusion techniques. This study was undertaken to determine the frequency of CCD observed in acute stroke by retrospective review of a research data base of patients with acute stroke evaluated by diffusion-weighted (DWI) and dynamic contrast susceptibility perfusion MR imaging (PWI). MATERIALS AND METHODS: PWI scans of 301 consecutive patients with acute stroke and positive DWI abnormality from a research data base were reviewed. Contralateral cerebellar hypoperfusion was identified by inspection of time-to-peak (TTP) maps for asymmetry with an absence of cerebellar abnormalities on T2-weighted scans, DWI, or disease of the vertebrobasilar system on MR angiography. In a subset of the cases, quantitative analysis of perfusion scans was performed using an arterial input function and singular value decomposition (SVD) to generate cerebral blood flow (CBF) maps. RESULTS: A total of 47 of 301 cases (15.61%) met the criteria of CCD by asymmetry of cerebellar perfusion on TTP maps. On quantitative analysis, there was corresponding reduction of CBF by 22.75 +/- 10.94% (range, 7.45% to 52.13%) of the unaffected cerebellar hemisphere). CONCLUSIONS: MR perfusion techniques can be used to detect CCD, though the frequency presented in this series is lower than that commonly reported in the PET/SPECT literature. Nevertheless, with its role in acute stroke and noninvasive nature, MR perfusion may be a viable alternative to PET or SPECT to study the phenomenon and clinical consequences of supratentorial stroke with CCD.
Authors: Ona Wu; Leif Østergaard; Walter J Koroshetz; Lee H Schwamm; Joanie O'Donnell; Pamela W Schaefer; Bruce R Rosen; Robert M Weisskoff; A Gregory Sorensen Journal: Magn Reson Med Date: 2003-10 Impact factor: 4.668
Authors: Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen Journal: Magn Reson Med Date: 2003-07 Impact factor: 4.668
Authors: Alessandro Cianfoni; Marco Luigetti; Marques L Bradshaw; Cynthia T Welsh; Jonathan Edwards; Steven Glazier Journal: J Neurol Date: 2010-05-15 Impact factor: 4.849
Authors: Wolfgang G Kunz; Wieland H Sommer; Christopher Höhne; Matthias P Fabritius; Felix Schuler; Franziska Dorn; Ahmed E Othman; Felix G Meinel; Louisa von Baumgarten; Maximilian F Reiser; Birgit Ertl-Wagner; Kolja M Thierfelder Journal: J Cereb Blood Flow Metab Date: 2017-01-13 Impact factor: 6.200
Authors: Cindy W Yoon; Sang Won Seo; Jun-Sung Park; Ki-Chang Kwak; Uicheul Yoon; Mee Kyung Suh; Geon Ha Kim; Ji Soo Shin; Chi Hun Kim; Young Noh; Hanna Cho; Min-Jeong Kim; Jong Hun Kim; Jee Hoon Roh; Jong-Min Lee; Duk L Na Journal: Cerebellum Date: 2013-02 Impact factor: 3.847
Authors: Vince I Madai; Andreas Altaner; Katharina L Stengl; Olivier Zaro-Weber; Wolf Dieter Heiss; Federico C von Samson-Himmelstjerna; Jan Sobesky Journal: J Cereb Blood Flow Metab Date: 2011-03-09 Impact factor: 6.200
Authors: Krishna A Dani; Celestine Santosh; David Brennan; Donald M Hadley; Keith W Muir Journal: J Cereb Blood Flow Metab Date: 2012-10-10 Impact factor: 6.200
Authors: Alexander Hertel; Holger Wenz; Mansour Al-Zghloul; Lucrezia Hausner; Lutz FrÖlich; Christoph Groden; Alex FÖrster Journal: In Vivo Date: 2021 Mar-Apr Impact factor: 2.155
Authors: K M Kang; C-H Sohn; B S Kim; Y I Kim; S H Choi; T J Yun; J-h Kim; S-W Park; G J Cheon; M H Han Journal: AJNR Am J Neuroradiol Date: 2015-07-30 Impact factor: 3.825